A) Vomiting

B) Diarrhea

C) Urinary retention

D) Bronchiolar constriction

E) Increase in intracranial pressure

A) (a) and (b) only

B) (a), (b) and (d)

C) (a), (d) and (e)

D) (c), (d) and (e)

E) All of the above

A) (a), (b) and (c)

B) (a), (b) and (d)

C) (a) and (e)

D) (c), (d) and (e)

E) All of the above

A) ASA

B) Codeine

C) Meperidine

D) Acetaminophen

E) Phenyibutazone

A) By binding to specific receptors in the CNS

B) By decreasing the influx of sodium

C) By decreasing the synthesis of prostaglandins

D) By decreasing nerve activatin at the site of injury

A) A direct irritant action on the gastric mucosa

B) Stimulation of the nodose ganglion of the vagus nerve

C) Stimulation of the medullary chemoreceptor trigger zone

D) Direct stimulation of the gastrointestinal musculature

A) Depression of cortical activity

B) Peripheral blockade of chemoreceptor impulses

C) An increase in carbon dioxide concentration in the blood

D) Blockade of afferent autonomic impulses from the lungs

E) Loss of sensitivity of the medullary respiratory center to carbon dioxide

A) A parasympathominetic action

B) Inhibiting the Herine-Bueuer reflex

C) Rendering the aortic chemoreceptor system insensitive to O2

D) Rendering the respiratory center in the brain stem less sensitive to changes in CO2

E) A specific effect at myoneural junctions of phrenic and intercostal nerves

A) Miosis, coma and depressed respiration

B) Mydriasis, coma and smooth muscle spasms

C) Mydriasis, coma and depressed respiration

D) Miosis, convulsions and depressed respiration

E) Mydriasis, convulsions and depressed respiration

A) Oxygen apnea

B) Cardiac arrest

C) Terminal convulsions

D) Circulatory collapse

E) Respiratory depression

A) Codeine

B) Methadone

C) Naloxone

D) Meperidine

E) Pentazocine

A) It has no analgesic properties

B) It may produce respiratory depression

C) As a mixed agonist-antagonist, it can elicit withdrawal symptoms

D) The high abuse potential of nalbuphine may add to the patient's problems

A) Aspirin

B) Pentazcine

C) propoxyphene

D) Indomethacin

E) Acetaminophen

F) None of the above

A) It is equianalgesic with codeine

B) It is a partial opioid antagonist

C) Its abuse potential is less than that of heroin

D) It may induce dysphoria and mental aberrations

E) It is effective only on parenteral administration

A) Naloxone

B) Nalorphine

C) Pentazocine

D) Levallorphan

E) Propoxyphene

A) Naloxone

B) Nalorphine

C) Cyclazocine

D) Levallorphan

E) None of the above

A) Precipitates withdrawal reactions

B) Antagonizes the depressant actions of morphine

C) Will not in itself produce physical dependence

D) Withdrawal reactions are less intense and stressful than those of morphine

A) Codeine

B) Methadone

C) Alphaprodine

D) Pentazocine

E) Meperidine

A) An antidepressant

B) An opioid analgesic

C) A sedative

D) A long-acting local anesthetic

E) An antipsychotic